Celularity Inc.

03/05/2026 | Press release | Distributed by Public on 03/05/2026 16:01

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On February 27, 2026, Joseph DosSantos, the SVP, Finance and Acting Chief Financial Officer of Celularity Inc. (the "Company") left the Company for personal reasons. On February 27, 2026, the Company appointed John Sprague as Acting Chief Financial Officer of the Company.

Celularity Inc. published this content on March 05, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 05, 2026 at 22:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]